Answers are grounded in this paper and cite their sources.
BACKGROUND: The purpose was to evaluate the prognostic impact of aryl hydrocarbon receptor (AHR) genotypes in relation to lifestyle and adjuvant treatments in breast cancer. METHODS: AHR genotyping was performed on genomic DNA from 1701 patients included 2002-2016 in Lund, Sweden, and followed for up to 15 years. Eight AHR polymorphisms and eight haplotypes were analysed using survival and interaction analyses in relation to prognosis. AHR genotypes were not prognostic in radiation therapy-treated patients. CONCLUSIONS: The prognostic impact of AHR genotypes depended on lifestyle and treatments, possibly due to the role of AhR as master regulator of metabolism, hypoxia, DNA repair and immune response. If confirmed, these findings may contribute to more personalised lifestyle recommendations and treatment.
No takes yet. Share an insight, caveat, or question.
Augustinsson et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: